Monoclonal Antibodies Stocks List Ranked for 2024

Symbol	Grade	Name	% Change
ADCT	D	ADC Therapeutics SA	-9.25
ATNM	C	Actinium Pharmaceuticals, Inc.	-8.57
ARDS	F	Aridis Pharmaceuticals Inc.	-6.40
APGE	D	Apogee Therapeutics, Inc.	-6.12
LXRX	F	Lexicon Pharmaceuticals, Inc.	-5.65
MRSN	F	Mersana Therapeutics, Inc.	-5.42
BCAB	D	BioAtla, Inc.	-5.09
BGNE	D	BeiGene, Ltd.	-3.98
FBRX	F	Forte Biosciences, Inc.	-3.16
GLPG	F	Galapagos NV	-2.74

Symbol	Grade	Name	Weight
KURE	D	KraneShares MSCI All China Health Care Index ETF	4.6
BBP	C	BioShares Biotechnology Products Fund	4.42
FBT	B	First Trust Amex Biotech Index Fund	3.71
BBH	B	Market Vectors Biotech ETF	3.19
IDNA	B	iShares Genomics Immunology and Healthcare ETF	3.17

Compare ETFs

Compare BBP to BBH Compare BBP to FBT Compare BBP to IDNA

Date	Stock	Title
May 21	BGNE	Glenmark to market BeiGene’s oncology medicines in India
May 21	FBRX	Companies Like Forte Biosciences (NASDAQ:FBRX) Could Be Quite Risky
May 20	BGNE	BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why
May 17	FBRX	Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
May 16	GLPG	Galapagos creates new subscription right plans
May 15	GLPG	Galapagos, BCA to collaborate on CAR-T cell therapy production
May 15	APGE	Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
May 15	GLPG	Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
May 15	MRSN	Mersana Therapeutics: On Hold While Waiting For Any Positive News
May 15	ATNM	Actinium to Host KOL Webinar to Discuss Iomab-ACT Commercial CAR T-Cell Therapy Trial Design, Objectives and Potential Market Opportunity
May 15	BCAB	BioAtla Inc (BCAB) (Q1 2024) Earnings Call Transcript Highlights: Strategic Adjustments and ...
May 15	BCAB	BioAtla, Inc. (BCAB) Q1 2024 Earnings Call Transcript
May 14	ATNM	Actinium Announces Oral Presentation Detailing Improved Survival Outcomes in TP53 Positive Patients at the EHA 2024 Annual Congress and Presentation of Long-Term Efficacy Results in Older Patients Receiving an Iomab-B Led Bone Marrow Transplant in the ...

Monoclonal Antibodies: Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.